Association Between Cannabis and Psychosis: Epidemiologic Evidence

Suzanne H Gage*, Matt Hickman, Stanley Zammit

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

147 Citations (Scopus)
1434 Downloads (Pure)


Associations between cannabis use and psychotic outcomes are consistently reported, but establishing causality from observational designs can be problematic. We review the evidence from longitudinal studies that have examined this relationship and discuss the epidemiologic evidence for and against interpreting the findings as causal. We also review the evidence identifying groups at particularly high risk of developing psychosis from using cannabis. Overall, evidence from epidemiologic studies provides strong enough evidence to warrant a public health message that cannabis use can increase the risk of psychotic disorders. However, further studies are required to determine the magnitude of this effect, to determine the effect of different strains of cannabis on risk, and to identify high-risk groups particularly susceptible to the effects of cannabis on psychosis. We also discuss complementary epidemiologic methods that can help address these questions.

Original languageEnglish
Pages (from-to)549-556
Number of pages8
JournalBiological Psychiatry
Issue number7
Early online date12 Aug 2015
Publication statusPublished - 1 Apr 2016


  • Cannabis
  • Epidemiology
  • Longitudinal studies
  • Marijuana
  • Psychosis
  • Schizophrenia

Fingerprint Dive into the research topics of 'Association Between Cannabis and Psychosis: Epidemiologic Evidence'. Together they form a unique fingerprint.

Cite this